Filing Details
- Accession Number:
- 0001415889-24-025393
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-17 18:34:47
- Reporting Period:
- 2024-10-15
- Accepted Time:
- 2024-10-17 18:34:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1736730 | Camp4 Therapeutics Corp | CAMP | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1867470 | Northpond Ventures Gp, Llc | 7500 Old Georgetown Road, Suite 800 Bethesda MD 20814 | No | No | Yes | No | |
1867472 | Northpond Ventures, Lp | 7500 Old Georgetown Road, Suite 800 Bethesda MD 20814 | No | No | Yes | No | |
1867627 | P. Michael Rubin | C/O Northpond Ventures 7500 Old Georgetown Road, Suite 800 Bethesda MD 20814 | No | No | Yes | No | |
1869114 | Northpond Ventures Ii Gp, Llc | 7500 Old Georgetown Road, Suite 800 Bethesda MD 20814 | No | No | No | No | |
1869128 | Northpond Ventures Ii, Lp | 7500 Old Georgetown Road, Suite 800 Bethesda MD 20814 | No | No | Yes | No | |
1972690 | Northpond Ventures Iii, Lp | 7500 Old Georgetown Road, Suite 800 Bethesda MD 20814 | No | No | Yes | No | |
2010695 | Northpond Ventures Iii Gp, Llc | 7500 Old Georgetown Road, Suite 800 Bethesda MD 20814 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-10-15 | 1,003,193 | $0.00 | 1,003,193 | No | 4 | C | Indirect | By Northpond Ventures II, LP |
Common Stock | Acquisiton | 2024-10-15 | 471,415 | $0.00 | 471,415 | No | 4 | C | Indirect | By Northpond Ventures, LP |
Common Stock | Acquisiton | 2024-10-15 | 763,636 | $11.00 | 763,636 | No | 4 | P | Indirect | By Northpond Ventures III, LP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | By Northpond Ventures II, LP |
No | 4 | C | Indirect | By Northpond Ventures, LP |
No | 4 | P | Indirect | By Northpond Ventures III, LP |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Prime Preferred Stock | Disposition | 2024-10-15 | 11,251,624 | $0.00 | 1,003,193 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2024-10-15 | 5,287,303 | $0.00 | 471,415 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Each share of Series A Prime Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on a 11.2158-for-one basis without payment of further consideration. Immediately prior to the closing of the Issuer's initial public offering, the Preferred Stock was converted into the number of shares of Common Stock of the Issuer shown in column 7 of Table II. The Preferred Stock had no expiration date.
- The shares are held directly by Northpond Ventures II, LP ("Northpond Fund II"). Northpond Ventures II GP, LLC ("Northpond II GP") is the general partner of Northpond Fund II, and Michael P. Rubin is the managing member of Northpond II GP. As a result, each of Northpond II GP and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund II. Each of Northpond II GP and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
- The shares are held directly by Northpond Ventures, LP ("Northpond Fund I"). Northpond Ventures GP, LLC ("Northpond GP I") is the general partner of Northpond Fund I, and Michael P. Rubin is the managing member of Northpond GP I. As a result, each of Northpond GP I and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund I. Each of Northpond GP I and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
- The shares are held directly by Northpond Ventures III, LP ("Northpond Fund III"). Northpond Ventures III GP, LLC ("Northpond III GP") is the general partner of Northpond Fund III, and Michael P. Rubin is the managing member of Northpond III GP. As a result, each of Northpond III GP and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund III. Each of Northpond III GP and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.